Wade Aubry, MD
Scientific Advisor, PHE
Associate Clinical Professor of Medicine and Core Faculty, Philip R. Lee Institute for Health Policy Studies, University of California San Francisco
Dr. Aubry’s research interests include health technology assessment, health plan and Medicare coverage decisions, state legislative coverage mandates, quality measurement, and managed care formularies. He has broad experience in clinical medicine and healthcare delivery as a practicing endocrinologist and former Chief of Staff for a community hospital. He has also served as medical director for a Medicare Administrative Contractor, a large Blue Cross Blue Shield Plan, and the Blue Cross Blue Shield Association, where he chaired its national technology assessment committee for 6 years. Other past experience includes senior positions with the Lewin Group, CTAF, CMTP, and HealthTech. He has served on several national advisory panels on medical technology, clinical research, and healthcare quality for CMS, NIH, AHRQ, IOM, and NCQA, where he has been an active member of its Geriatrics Measurement Advisory Panel since the 1990s. His work has been published in leading peer-reviewed journals, and he is also co-author of a comprehensive case study on the rise and fall, and lessons, of bone marrow transplantation for breast cancer. He has served as a consultant for numerous medical device, diagnostics, and pharmaceutical companies on evidence development, value assessment, and coverage and reimbursement strategy.
MD, University of California, Los Angeles
BS, Biological Sciences, Stanford University
- Chemew ME, et al. Comparative effectiveness research and formulary placement: the case of diabetes. Am J Manag Care. 2013.
- Coffman JM, et al. Translating medical effectiveness research into policy: lessons from the California Health Benefits Review Program. Milbank Q. 2009.
- Hoffman A, et al. How best to engage patients, doctors, and other stakeholders in designing comparative effectiveness studies. Health Aff (Millwood). 2010.
- Sussell J, et al. Value-based payments and incentives to improve care: a case study of patients with type 2 diabetes in Medicare Advantage. Value in Health. 2017.